Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
CNBC - 2024-04-17T15:23:17.000Z

The insatiable demand for weight loss and diabetes drugs is still trouncing supply, even as Eli Lilly and Novo Nordisk work to increase production capacity. Read this story